- Home
- VLO vs EW Comparison
VLO vs EW Comparison
Compare VLO & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VLO | EW |
|---|---|---|
| Founded | 1980 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Industrial Specialties |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.9B | 50.2B |
| IPO Year | 1997 | 1999 |
Fundamental Metrics
Financial Performance| Metric | VLO | EW |
|---|---|---|
| Price | $214.13 | $86.91 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 21 |
| Target Price | ★ $184.24 | $96.47 |
| AVG Volume (30 Days) | 2.4M | ★ 4.9M |
| Earning Date | 04-29-2026 | 05-13-2026 |
| Dividend Yield | ★ 2.35% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 7.57 | 1.83 |
| Revenue | ★ $122,687,000,000.00 | $6,067,600,000.00 |
| Revenue This Year | N/A | $13.19 |
| Revenue Next Year | $3.74 | $9.81 |
| P/E Ratio | ★ $27.02 | $47.42 |
| Revenue Growth | N/A | ★ 11.55 |
| 52 Week Low | $99.00 | $65.94 |
| 52 Week High | $206.77 | $87.89 |
Technical Indicators
Market Signals| Indicator | VLO | EW |
|---|---|---|
| Relative Strength Index (RSI) | 71.33 | 66.89 |
| Support Level | $160.30 | $81.61 |
| Resistance Level | N/A | $87.20 |
| Average True Range (ATR) | 6.10 | 2.44 |
| MACD | 0.52 | 1.16 |
| Stochastic Oscillator | 92.96 | 98.28 |
Price Performance
Historical ComparisonAbout VLO Valero Energy Corporation
Valero Energy is one of the largest independent refiners in the United States. It operates 15 refineries, with a total throughput capacity of 3.2 million barrels a day in the US, Canada, and the United Kingdom. Valero also owns 12 ethanol plants with capacity of 1.6 billion gallons a year and holds a 50% stake in Diamond Green Diesel, which can produce 1.2 billion gallons per year of renewable diesel.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.